NCT06984640View on ClinicalTrials.gov

Curcumin Supplementation for the Improvement of Diabetes-related Outcomes

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 16, 2023

Primary Completion Date

February 14, 2024

Study Completion Date

February 13, 2025

Conditions
Over Age 60Prediabetes or Overweight
Interventions
DIETARY_SUPPLEMENT

Curcumin

Each capsule contained 400 mg of a patented lipophilic matrix, delivering 80 mg of curcumin. Longvida® is a trademark of Vendure Sciences, Noblesville, IN, USA.

DIETARY_SUPPLEMENT

Placebo

Each capsule contained 400 mg of a patented lipophilic matrix, delivering 80 mg of curcumin.

Trial Locations (1)

74078

Laboratory for Applied Nutrition and Exercise Science (LANES), Stillwater

All Listed Sponsors
lead

Oklahoma State University

OTHER